弘星相和完成近亿元Pre-A轮融资，北极光创投领投
Sou Hu Cai Jing·2025-09-17 01:20
Group 1 - Hongxing Xianghe Biotechnology Co., Ltd. has completed nearly 100 million RMB in Pre-A round financing [1] - The financing round was led by Northern Light Venture Capital, with participation from Dongwei Fund, DCG Holdings, Dingfu Investment, and Future Qichuang Fund [1] - Existing angel round shareholder Xingyao Taihao Fund has also increased its investment in this round [1]